[ASND] YoY Quarter Result on 30-Sep-2015 [#Q3]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
25-Aug-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 51.39%
YoY- -269.19%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 2,243 20 434 1,169 2,117 3,250 6,068 -15.27%
PBT -25,174 -34,067 -34,117 -18,311 -7,470 -1,931 1,542 -
Tax -61 -100 -240 -57 -160 49 826 -
NP -25,113 -33,967 -33,877 -18,254 -7,310 -1,980 716 -
Tax Rate - - - - - - -53.57% -
Total Cost 27,356 33,987 34,311 19,423 9,427 5,230 5,352 31.23%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -1,119.62 -169,835.00 -7,805.76 -1,561.51 -345.30 -60.92 11.80 -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.53 -0.81 -1.04 -0.72 -0.30 -0.12 0.07 -
EPS Diluted -0.53 -0.81 -1.04 -0.72 -0.30 -0.12 0.07 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.